Citigroup Maintains Neutral on Pfizer, Raises Price Target to $30
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
Citigroup analyst Geoff Meacham maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $30.
Citigroup analyst Geoff Meacham maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $30.